Nanologica’s Year-End Report 2022
FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 674 (676) and for the full year to TSEK 1,555 (12,914) The operating loss for the quarter amounted to TSEK -13,251 (-14,108) and for the full year to TSEK -50,850 (-40,689) Loss after tax for the quarter amounted to TSEK -14,855 (-15,222) and for the full year to TSEK -55,231 (-44,829) Earnings per share before and after dilution were SEK -0.42 (-0.54) for the